The FDA is targeting telehealth marketing of GLP-1 drugs. But those companies may not be the only ones under the microscope.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results